chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from the health professional referring to an unspecified number of patients of unknown demographics. Relevant medical history, concurrent conditions and drug reactions/allergies of these patients were not reported. On unknown dates, these patients were vaccinated with improperly stored ROTATEQ (lot # K001948, expiry date: 07-JUN-2017; lot # K020181, expiry date: 24-JUN-2016; lot # K014826, expiry date: 28-MAY-2016). Concomitant medications were not reported. No adverse effects were reported. This is one of the three reports received from the same reporter. Additional information has been requested.
This spontaneous report was received from a licensed vocational nurse refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 22-OCT-2015, the patient was vaccinated with a dose of VARIVAX (Merck), lot # L006383 and expiration date 25-MAR-2017 (dose, route of administration and anatomical location were not provided). There were no concomitant medications reported. No adverse effect was reported. No product quality issue was involved. This is one of several cases from the same reporter. Additional information has been requested.
Headache, tightness in chest, legs hurting from my knees down, hard to focus vision, and super tired. started about an hour later. Did not sleep well. Stayed in bed the next 2 days.  Tightness in chest went away the second day. Third day I felt like myself.  These were things that I also experienced with Covid.
Delayed anaphylactic reaction.  Evening of receiving injection he didn't feel well, oxygen dropped to 80s on pulse ox and patient self administered epi pen at home and went back to sleep. Later this happened again and he developed throat closing and gave himself a second shot. He went to the ER the following day 7/26/21 where he received treatment with dexamethasone, pepcid, and benadryl. He also had labwork completed, EKG, and Chest xray. He did well with treatment and was discharged home.
Pt vaccinated with MMR developed headache, sore throat, aching all over, testicle rt & lt pain, nausea off and on and some dizziness.  Went to Dr's office X 2.
Case number PHEH2014US024275, is an initial spontaneous report received from a nurse on 02 Dec 2014, and with a follow up report received from nurse on 21 Jan 2015. This report refers to a 53 year old male patient. Medical history and concomitant medication were not reported. He was vaccinated with FLUVIRIN (batch number: 14511P, expiry date: Mar 2015) intramuscularly into left deltoid at a dose of 0.5 ml on 16 Nov 2014. Nurse reported that PFS of FLUVIRIN was stored at 49 degree F for 1 hour and 15 minutes. No adverse event was reported following this maladministration. No further information was provided. Follow up report received from nurse on 21 Jan 2015. Updated site of vaccination.
Information was received from a nurse practitioner reporting a patient fainted after receiving GARDASIL. The patient come up to the window to check out. She left light-headed and sat down on floor. The patient was monitored for 15-20 minutes and she was fine. No further information is available.
the inflammation multiples by 10; the inflammation multiples by 10; This is a spontaneous report from a contactable consumer (patient). This consumer reported same event for same patient, different vaccine dose. This is the second dose.  A 33-year-old (also reported as 32 years old) non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: Ew0177, expiration date not provided), 2nd dose via an unspecified route of administration, administered in Arm Right on 14May2021 16:00 at age of 33 years old as a single dose for COVID-19 immunisation. Medical history included ankylosing spondylitis. Concomitant medications included diazepam (VALIUM); naproxen (NAPROXEN ). The patient previously took vancomycin, rocephin biochemie, latex, BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: Ew0161, expiration date not provided), 1st dose via an unspecified route of administration, administered in Arm Right on 23Apr2021 15:00 as a single dose for COVID-19 immunisation and experienced severe inflammation in my neck, spine, shoulders, elbow, wrist, fingers, knees, ankles. The patient experienced severe inflammation in her neck, spine, shoulders, elbow, wrist, fingers, knees, ankles. This was present after the first shot. After the second shot on 14May2021 the inflammation multiples by 10 in 2021. Therapeutic measures were taken as a result of the inflammation multiples by 10. The outcome of the event was not recovered. The report was reported as non-serious by reporter. The patient was not pregnancy at time of vaccination. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. The adverse event result in visiting doctor or other healthcare professional office/clinic visit. Treatment for the adverse event was included prednisone. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021572514 same patient/event, different vaccine doses
Vaccine not removed from freezer at 2 wk mark- at 3 wks and administered Pfizer conslut cKDNE 1mm/ mauf. Notified pt offer repeat dose- opted to repeat  and repeated 1/24/22.
My heart started racing within a couple of minutes. I felt nauseous and my throat felt like it was closing. My mouth got dry. I had my son with me and didn?t want to scare him so I kept taking deep breaths and focusing on whether the side effect were getting worse. They didn?t. After another 5 minutes I could fee the pressure in my throat lessening and my heart rate slowed. It was terrifying but I?m thankful it didn?t progress. I didn?t seek assistance from the personnel on site. I was aware of what was going on but I?ve had anxiety attacks in the past and thought that was what it may have been until I read that an allergic reaction feels the same. If the second dose is stronger I don?t think it would be wise to attempt receiving that one.
Severe stomach pains, resulting in appendicitis and emergency appendectomy.  Ongoing headaches., scheduled for a brain MRI
awoke with chills fever nausea  diarhea as well as tinitus and dizziness
Numbness, pain, electric shocking  feeling and cramping in both my arms, hands, legs and feet. Also numbness feeling on left side of face, left top and bottom lip and my tongue.
when I put my arm back to wash myself there is some pain; Faint ache -not earth shattering; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (when I put my arm back to wash myself there is some pain) and VACCINATION SITE PAIN (Faint ache -not earth shattering) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     The patient's past medical history included Bypass surgery (he had triple bypass 13. years ago).   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (when I put my arm back to wash myself there is some pain) and VACCINATION SITE PAIN (Faint ache -not earth shattering). At the time of the report, PAIN IN EXTREMITY (when I put my arm back to wash myself there is some pain) and VACCINATION SITE PAIN (Faint ache -not earth shattering) outcome was unknown.            No treatment medications were taken.  Patient was prescribed with stent medication but doesn't know what name and patient is not taking it currently. Action taken with mRNA-123 is not applicable.
3 days after vaccines patient developed fever to 101 degrees, arthralgias, and localized reaction at shot sites, red, warm about 6 am.
Information has been received from a healthcare worker concerning an unspecified number of patients of unknown age and gender. No concurrent or historical conditions were reported. On unspecified dates, the patient was vaccinated with PROQUAD (route, dose, Lot# and expiration date not reported), but the vaccines had been exposed to temperatures warmer than 5F, which was outside of the recommended range. No adverse effects have been observed or reported. This is one of several reports received from the same reporter. Additional information has been requested.
At 5 weeks, 5 days pregnant I received the 1st Covid-19 dose. I started bleeding the evening of Feb. 7, 2021. The bleeding continued to increase. I visited the Emergency Department on Feb. 10, 2021 and learned my baby had died around 7 weeks into the pregnancy.
pt recv vax 11JUN97 & 6JUN97 pt exp parotitis & was seen by MD 9JUL97;diagnostic test included CBC, Amylase & mumps IgM;
Chills, Weak Muscles started about 2 days after vaccination. Significant. Pt went to hospital.
Patient reported to pharmacy approximately 1 year after receiving vaccination to inquire about whether adverse events that he had been experiencing were normal. Patient complained of arm pain ever since receiving the vaccination that has failed to improve fully over time. Still limits his ability to use that arm for recreational and daily activities. He also complains of a lump at the injection site.
pt recv vax in 2 days OCT96 hives, swollen lip, tongue, sore arm;
2 wks p/vax pt got a rash from head to toes; It lasted 4 days;
FELT VERY SICK THE NEXT DAY AND FOR 4 DAYS THERE AFTER; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On MAR-2021, the subject experienced i felt very sick the next day and for 4 days thereafter. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of felt very sick the next day and for 4 days thereafter was not reported. This report was non-serious.
Information has been received from a consumer concerning her friend's son (age not reported) who on approximately 26-JUL-2007 was vaccinated with his second dose of varicella virus vaccine live (Oka/Merck). In August 2007, the patient broke out with a significant amount of chicken pox lesions. No further information was given. No further information is available.
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 56-year-old male patient received BNT162b2 (BNT162B2), on 10Jun2022 at 17:00 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 57 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "hypertension" (unspecified if ongoing); "hx PE" (unspecified if ongoing); "DVT" (unspecified if ongoing). There were no concomitant medications.  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Positive Covid test 6 days after testing negative, 9 days after completing 5 days of Paxlovid; Negative, notes: Positive. Covid test 6 days after testing negative, 9 days after completing 5 days of Paxlovid. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Patient did not have known allergies. Patient received Paxlovid from 12Aug2022 to 16Aug2022 for treatment of COVID-19. Patient experienced congestion, Cough, Body Aches. Positive Covid test 6 days after testing negative, 9days after completing 5 days of Paxlovid.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Fever of 100F, 11/17/99 PM, felt hot, swelling in left upper arm near the site area and above. Unable to raise left arm due to pain.
Pfizer BioNTech Vaccine administered (patient also took paxlovid for covid-19 treatment after received BNT162b2); Pfizer BioNTech Vaccine administered(patient also took paxlovid for covid-19 treatment after received BNT162b2); This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 50-year-old male patient received BNT162b2 (BNT162B2), on 02Jan2022 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 50 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for 5 days and as dose 2, single (Batch/Lot number: unknown) for 5 days for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant) with onset 18Apr2022, outcome "unknown", described as "PAXAES report with Pfizer BioNTech Vaccine administered (patient also took paxlovid for covid-19 treatment after received BNT162b2)"; COVID-19 (medically significant) with onset 18Apr2022, outcome "recovered" (01May2022), described as "PAXAES report with Pfizer BioNTech Vaccine administered(patient also took paxlovid for covid-19 treatment after received BNT162b2)". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Covid positive; negative, notes: tested negative; positive, notes: then again at day 12 positive. Therapeutic measures were taken as a result of covid-19.  Additional information: Treatment: Anti-viral details Plaxovid, Treatment start date: 04Apr2022, Treatment stop date: 08Apr2022, Treatment of COVID-19, Administrator route: Oral. Adverse event: Covid positive tested with upper Respiratory symptoms: started plaxovid on day 2 of positive -treatment for 5 days - symptom free after day 3 - reoccurrence of symptoms at day 11 - in between tested negative, and then again at day 12 positive. Patient did not receive any medication two weeks prior vaccination. Patient had no known allergies.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on the current available limited information in the case provided, the causal association between the events and the use of suspect product BNT162B2 cannot be fully excluded.
about 12 hours after receiving the 2nd dose of vaccine patient started with Chills, Body Aches, Fever, Headache. Stated that a few hours later she started with diarrhea
I received the vaccine at approximately 7:45pm.  At approximately 3:00am, I awoke with shortness of breath and my lungs felt heavy.  I was also wheezing.  I used my inhaler, but it did not alleviate my symptoms.  I waited to see if the symptoms would go away on their own; however, they did not.  Six days later I went to see the Dr. and he prescribed a course of prednisone and told me to continue using my inhaler as needed.  After I was finished taking the prednisone, I did feel better; however, I do still experience shortness of breath from time to time.
This patient complains that since 01/14/00, he has had pain to the deltoid area. Pain is worse in the AM. The pain goes from the shoulder to the fingers. The patient uses pain cream and finds relief sometime all day.
Information has been received from an office manager referring to multiple unspecified patients of unknown age and gender. Information regarding concomitant medication, medical history and drug reactions/allergies was not reported. On unknown dates, the patients were vaccinated with improperly stored doses of PROQUAD (lot # was reported as M031568, expiration date 24-DEC-2017; dose and route were not reported). It was reported that the vaccine was improperly stored at -5.6 Celsius (C) for 1 hour and was then back in range. Prior temperature excursions included -12.4 C for 30 minutes and -12.7 C for 26 minutes. No adverse effects were reported. Data logger was involved. This is one of two reports received from the same reporter. Additional information has been requested.
Did not authorize Pedarix signed for just DTap. Incorrect vaccine given without consent to a four month old
This patient was scheduled for the Covid-19 Pfizer Bivalent vaccine but was actually given the Covid-19,mRNA, LNP-S,  PF, 30 mcg/0.3ml dose, tris-sucrose  Pfizer vaccine.  This patient was notified by phone and rescheduled in two months to receive the Covid-19 Pfizer Bivalent vaccine.  She agreed to come back for the appointment in two months.  She reported no adverse symptoms at this time.
pain in arm; Chills; Aches; This case was reported by a consumer and described the occurrence of pain in arm in a 62-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than a year after receiving Shingrix, the patient experienced pain in arm, chills and pain. Shingrix was discontinued. On an unknown date, the outcome of the pain in arm, chills and pain were recovered/resolved.   It was unknown if the reporter considered the pain in arm, chills and pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported but it could be 61 years or 62 years. The patient received 1st dose of Shingrix 11 months before the date of reporting. The patient had been putting off 2nd dose of Shingrix because after 1st dose, the pain in arm, chills and aches made the patient miserable for 3 days. The patient informed the doctor and the doctor advised to receive 2nd dose. The patient also had the other vaccine about 8 years ago and asked about total effective resistance to shingles now without 2nd dose of Shingrix.
Severe headache; This is a spontaneous report from a contactable consumer. This consumer reported for a female patient (reporter's sister-in-law).  A female patient of an unspecified age received first and second dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, on an unknown date, as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter (67-year-old) reported that the reporter received the first dose of the Pfizer COVID vaccine on 28Jan2021 at 10:45 am. Yesterday at 3:15 pm the reporter practically passed out and couldn't stand up. The reporter was pretty healthy and didn't drink anymore. Things like that used to happen when the reporter drank but not now. The reporter hope it wasn't something neurologic going on with the reporter's body. The reporter also reported that the patient (reporter's sister-in-law) just got her second shot yesterday. On an unknown date, she had a severe headache 5 days after getting the first dose of the vaccine. The reporter asked was it possible to have a side effect from the vaccine that many days later. The reporter just wanted to thank Pfizer for coming up with this medication to help millions of people and was looking forward to getting second dose. Outcome of the event was unknown.  Information on lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
This is a spontaneous report from a contactable Nurse via Pfizer sales representative. A 18-year-old male patient of an unspecified ethnicity received TRUMENBA, at 0.5 ml, single and human papilloma vaccine (HPV9), both via an unspecified route of administration on an unspecified date. The patient medical history and concomitant medications were not reported. The patient experienced dizzy and lips were pale on an unspecified date with outcome of unknown. No follow-up attempts possible. No further information expected.
10-month-old who presents 1 day after her first influenza vaccination with a rash. Patient was fussy yesterday and had difficulty sleeping last night. This morning at 10 AM the day care staff noticed welts on her wrists and knees. Mom went to evaluate her at lunch time and noted that her wrists and knees were hard and hot. Patient was increasingly fussy today. There are no known ill contacts. There is strep in some of the other classrooms at the child's daycare. Mom brought her directly from the daycare to the ED.
Pt vaccinated with Fluzone developed temp. not recorded, but believed to be over 37 chills, weakness, asthma worsened.
This spontaneous case was initially received on 19-Oct-2015. The case report was received from a Non Health Professional and concerns a 64 years old female patient. Weight: not provided, Height: not provided. The patient received AFLURIA on unknown dates, Batch no: not provided, Route of administration: Intramuscular, Dose: Administered: ??-Nov-2015. No additional drugs suspected. On an unknown date, after starting treatment with AFLURIA the patient experienced More tired, severe headaches, and tension headaches. Reporter's assessment: The headaches went away and now she gets unrelated tension headaches that she insists had no connective with AFLURIA.
This case was reported by a healthcare professional and described the occurrence of lichen planus in a 38 year old male subject who was vaccinated with TWINRIX (Glaxosmithkline). A physician or other healthcare professional has not verified this report. On an unspecified date the subject received unspecified dose of TWINRIX (unknown). At an unspecified time after vaccination with TWINRIX, the subject experienced lichen planus. At the time of reporting the event was unresolved. The reporter stated that this event occurred months ago. Follow-up information was received on 01 September 2009, via healthcare professional, who reported the Lichen planus onset date was 07 January 2009. Biopsy was performed. At the time of the report, the event was unresolved. The healthcare professional considered the event possibly related to vaccination with TWINRIX.
Patient's reaction(s) noted during COVID vaccine observation period: dizziness  Actions Taken: VS taken x2, both sets WNL. Pt decided she felt good enough to go home.  Disposition: Patient declined ED visit
High fever, pain, swelling, cellulitis like reaction, scarring.  Nurse follow up on 07/21/04 states: "erythema, induration, rash, draining site, pustules."
Narrative :  Symptoms: HYPERtension, Tachycardia & FLUSHING, SWEATY  Treatment:
On June 12, 1999 the pt developed varicella with less than 50 lesions that were mainly papular and non-localized. It was indicated that her condition intensified through June 14, 1999. Treatment with acyclovir was initiated and followed by resolution of the sx. The reporter expressed concern with the vax lot and believed there was an association between the pt sx and the vax.
I was the first J&J vaccine patient on April 1 @1pm at the pharmacy.  I developed a bruise around the injection site (like a bull's eye) afterwards and I still have it on my arm though slightly lighter but still visible.  I wonder if it is related to blood clotting that's been reported in the news lately.  I thought I'd report it just in case.  I also had a small itchy rash of tiny red dots for about 3 days which started about 4 days post injection.  I have no previous issues with vaccinations or any bleeding concerns.  This is odd.  I developed alternating low grade fever ~99.1 F and chills with fatigue for 2 days after the jab too but that's not unusual for me after the seasonal flu vaccines.